ZNF165:具有预后和治疗潜力的泛癌生物标志物
1Scientific Research Center, Dongguan Labway Medical Testing Laboratory Co., Ltd., Dongguan, 523429, China.
Protein and peptide letters
|January 27, 2025
概括
在许多癌症中,ZNF165基因失调,影响患者的生存和免疫反应. 准ZNF165对新型癌症免疫疗法有很大的前景.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 免疫学 免疫学 免疫学
背景情况:
- 已确定ZNF165在肝,胃和乳腺癌中的作用.
- 它影响瘤免疫微环境,增殖和迁移.
- ZNF165是癌症免疫治疗的潜在目标.
研究的目的:
- 为了研究ZNF165.5.的泛癌景观.
- 了解它对癌症发展和患者结果的影响.
- 探索ZNF165在瘤免疫微环境和药物反应中的作用.
主要方法:
- 使用了在线数据库 (TIMER,TCGA,GTEx,GEPIA2,cBioPortal,TIMER2) 和进行统计分析.
- 评估了ZNF165表达,临床相关性和与MSI,TMB和免疫透的关联.
- 研究了基因变异,信号通路,药物反应和单细胞表达模式.
主要成果:
- 在各种癌症中,ZNF165表达变化,与KIRC,KIRP,STAD和UCEC的临床阶段和低生存率相关.
- 在ZNF165和MSI,TMB,免疫细胞透和免疫检查点基因表达之间发现了显著的关联.
- ZNF165与癌症进展,化疗反应和化学抵抗有关,在卵巢癌中发现了一个ceRNA网络.
结论:
- ZNF165表现出泛癌失调,并与关键的癌症特征有关.
- 它与免疫标记物和临床结果的关联表明它在瘤发生中起着重要作用.
- 在人类癌症治疗中,ZNF165是一个有前途的治疗标.
更多相关视频
相关概念视频
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K


